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Abstract 
Purpose: Decision making regarding the urethra before and after radical cystectomy due to urothelial carcinoma has 
always been controversial. To determine whether anterior urethra sparing cystoprostatectomy for bladder cancer is an 
oncologically-safe procedure, we evaluated the long-term oncologic clinical outcome.
Patients and methods: A total of 51 male patients with cTa-4N0-2M0 bladder cancer were treated with anterior ure-
thra sparing cystoprostatectomy and simultaneous urinary diversion between 2000 and 2013, and underwent follow 
up for 4 months or more. We assessed differences in the perioperative outcomes, oncologic outcomes and recurrence 
rates according to the urinary diversion.
Results: The median patient age and follow-up period were 66 years and 35 months, respectively. The 5- and 10-year 
recurrence free survival (RFS) rates in ileal conduit (IC) group vs. orthotopic neobladder reconstruction (NB) group 
were 45.0 and 20.3% vs. 39.3 and 19.6%, respectively. Likewise, the 5- and 10-year disease specific survival (DSS) were 
52.7 and 32.1% vs. 39.3 and 29.5%, respectively. Multivariate analysis revealed two independent prognostic factors 
for RFS and DSS, including age at surgery and lymph node status. Local recurrence in the remnant anterior urethra 
occurred in only 1 patient (2.0%) at 57 months after surgery.
Conclusions: Our long-term data show that anterior urethra sparing cystoprostatectomy is an oncologically-safe 
procedure regardless of the type of urinary diversion in a subset of carefully selected patients with bladder cancer 
without evidence of urothelial carcinoma in the urethra/bladder neck and urethral surgical margin.
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Background
Radical cystoprostatectomy is the standard treatment 
in men with muscle-invasive bladder cancer (MIBC) or 
refractory high risk non-MIBC (Gakis et al. 2013; Stenzl 
et  al. 2011). This includes removal of the bladder, pros-
tate, seminal vesicles and vasa deferentia (Gakis et  al. 
2013). The overall incidence of urethral recurrence (UR) 
in contemporary cystectomy patients is 4–6%. In patients 
undergoing orthotopic bladder replacement, the inci-
dence is lower (Huguet 2013; Huguet et al. 2008; Huguet 
2012; Stein et  al. 2005; Boorjian et  al. 2011). The most 
consistent risk factor associated with the occurrence of 
UR is the involvement with urothelial prostate tumor, 
and especially, prostatic stromal involvement (Stein et al. 
2005; Nieder et al. 2004; Hardeman and Soloway 1990).
Perineal urethrectomy is indicated with cystectomy in 
male patients in the presence of urethral involvement by 
cancer or if there is a risk of urethral reinvolvement, such 
as a positive prostatic urethral margin, prostatic urethral 
superficial urothelial carcinoma (UC) or prostatic stro-
mal invasion (Cho et al. 2009). It has been also reported 
to be a more complicating procedure as a result of the 
additional perineal wound, longer operation duration 
and delayed ambulation (Elshal et  al. 2011). Therefore, 
it remains a controversial matter whether simultane-
ous prophylactic urethrectomy or urinary diversion with 
Open Access
*Correspondence:  nozomih0331@gmail.com 
1 Department of Urology, Saiseikai Kawaguchi General Hospital, 
Nishikawaguchi, Kawaguchi, Saitama, Japan
Full list of author information is available at the end of the article
Page 2 of 5Hayakawa et al. SpringerPlus  (2015) 4:401 
radical cystoprostatectomy should be performed even for 
cases in which the principal risk factors for UR have been 
identified preoperatively. Moreover, there are few reports 
of remnant urethral recurrence in male patients undergo-
ing ileal conduit with no prophylactic urethrectomy.
We present our experience in evaluating whether 
anterior urethra sparing cystoprostatectomy for blad-
der cancer influences into the incidence of remnant 
urethral recurrence and subsequent oncologic clinical 
outcome, based upon differences of simultaneous urinary 
diversion.
Results and discussion
Clinical presentation, diagnosis, and pathological findings
Ultimately, a study population of 51 males with cTa-
4N0-2M0 bladder cancer undergoing anterior urethra 
sparing cystoprostatectomy and simultaneous urinary 
diversion was eligible for analysis. The patient char-
acteristics are summarized in Additional file  1: Table 
S1. The median age of the patients was 66  years (range 
48–84  years). Of the 56 consecutive patients, 5 patients 
were excluded for the following reasons: 2 patients had no 
urinary diversion caused by chronic renal failure requiring 
maintenance hemodialysis among their comorbid disor-
ders, 2 patients had undergone percutaneous ureterostomy 
as urinary diversion and bone metastasis, and the another 
one patient was diagnosed as having squamous cell carci-
noma post-pathologically. IC and NB were selected as the 
approach to urinary diversion in 25 (49.0%) and 26 (51.0%) 
patients, respectively. The median follow up time was 
35 months (range 4–143 months). Upon review of the final 
cystoprostatectomy specimen, the presence of carcinoma 
in situ (CIS), non-organ confined disease (pT3 or greater), 
and node-positive disease were evident in 10 (19.6%), 19 
(37.3%), and 9 (17.6%) patients, respectively. A total of four 
patients (7.9%) demonstrated prostatic urethral involve-
ment. While one patient had pathological prostatic ductal 
disease, three exhibited stromal involvement. There were 
no differences in the presence of CIS, pathological stage, 
UC grade, and prostate involvement when comparing 
patients undergoing IC vs. NB urinary diversion.
Perioperative outcomes and complications
The median operation time was significantly shorter for 
the IC group (546  min) compared with the NB group 
(594  min) (P =  0.027), However, there were no statisti-
cal differences in the median blood loss or the number of 
hospitalization days between these subgroups (1,500 vs. 
1,700 ml and 47 vs. 41 days in the IC group vs. NB group, 
respectively) (Additional file  2: Table S2). The surgical 
margins were tumor free for all cases.
While there was no perioperative mortality, a total 
of 19 (37.3%) patients experienced perioperative 
complications. Both ileus and pyelonephritis occurred 
as the most frequent complication in 4 (7.8%) patients 
each. There was no significant impact on the complica-
tion rate and type between these subgroups (Additional 
file 3: Table S3).
Oncologic outcomes and recurrence rates according to the 
site in patients with postoperative recurrence
Five- and 10-year RFS by Kaplan–Meier estimation 
in IC group vs. NB group were 45.0 and 20.3% vs. 39.3 
and 19.6%, respectively (p  >  0.05) (Fig.  1). Similarly, 
the 5- and 10-year DSS were 52.7 and 32.1% vs. 39.3 
and 29.5%, respectively (p  >  0.05) (Fig.  2). Multivariate 
analysis revealed three independent prognostic factors 
for RFS, including age at surgery (p =  0.03), maximum 
pathological tumor stage (p =  0.01), lymph node status 
(p  =  0.0001) and two independent prognostic factors 
for DSS, including age at surgery (p  =  0.006), lymph 
node status (p = 0.03) (Additional file 4: Table S4). None 
of the other factors tested proved to be of prognostic 
Fig. 1 Actual recurrence free survival in 51 patients stratified by the 
type of urinary diversion.
Fig. 2 Actual disease specific survival in 51 patients stratified by the 
type of urinary diversion.
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significance. Patients with lymph node-positive disease 
or who were over 60 years old demonstrated significantly 
worse survival and higher recurrence rates than those 
with no lymph node involvement or who were under 
60  years of age (p =  0.013 and 0.001 or p =  0.001 and 
0.001, respectively). Recurrence developed during fol-
low-up in 20 of the 51 patients (39.2%), including distant 
recurrence of abdominopelvic lymph node, lung, bone, 
liver and local recurrence of muscle, rectum, ureter and 
remnant urethra (Additional file 5: Table S5). A total of 
9 patients (17.6%), comprised of 6 in the IC group and 3 
in the NB group presented with distant, as well as local 
recurrences. Remnant urethral recurrence was identified 
in only one patient in the NB group (2.0%) at 57 post-
operative months, although other recurrence sites were 
more frequently confirmed during the same follow-up 
period. There were no significant differences in the recur-
rence rates according to the site in patients with postop-
erative recurrence between each subgroup. 
Decision making regarding the urethra before and 
after radical cystectomy due to urothelial carcinoma has 
always been controversial (Huguet 2011). The incidence 
of urethral recurrence of UC after radical cystectomy 
has been estimated to be as high as 10% (Freeman et al. 
1994). Significant attention has been directed toward 
determining appropriate patient selection for urethral 
preservation and orthotopic neobladder reconstruction. 
It is generally accepted that orthotopic diversion should 
not be performed if there is a high risk of tumor recur-
rence in the retained urethra. While the pathological 
features considered as potentially high risk have evolved 
during the last decade, with some of these factors sur-
geons continue to consider prophylactic urethrectomy, 
thereby precluding orthotopic diversion (Hassan et  al. 
2004). These characteristics include prostatic urethral 
involvement in men, bladder neck and/or vaginal wall 
involvement in women and CIS (Freeman et al. 1996). By 
contrast, there have been few reports in which intraoper-
ative frozen section biopsies of the urethral margin have 
been used systematically and with sufficient follow-up; 
although most authors currently agree that this approach 
would determine whether orthotopic diversion or ure-
threctomy should be performed (Huguet 2011). Kassouf 
et  al. (2008) reported that a positive preoperative tran-
surethral resection prostatic urethral biopsy did not cor-
relate with final margin and should not exclude patients 
from consideration for orthotopic urinary diversion in 
their study of 245 radical cystectomy specimens for UC. 
There are also a few reports of remnant urethral recur-
rence in male patients who had undergone the ileal con-
duit procedure without prophylactic urethrectomy. Based 
on these reports, we hypothesized that simultaneous pro-
phylactic urethrectomy with radical cystoprostatectomy 
might not always be necessary, regardless of the type of 
urinary diversion, if the urethral margin alone was nega-
tive on frozen section. In our series, surgical margins 
were confirmed to be tumor free for all cases. Therefore, 
prophylactic urethrectomy was not performed and the 
types of urinary diversion were divided into IC and NB 
groups, according to the complete assessment of several 
factors, including patient age, patient desire, preoperative 
complications, past history of digestive disease, intraop-
erative findings, such as the length of the mesentery or 
the presence of some adhesion. As shown in Additional 
file  1: Table S1, there were no significant differences in 
the patient background among those patients undergoing 
IC vs. NB urinary diversion. As a result, the histopatho-
logical findings in our retrospective study revealed that 
4 patients (7.9%) exhibited prostatic involvement even 
if the negative urethral surgical margin was confirmed 
intraoperatively. However, remnant urethral recurrence 
was identified in only one patient (2.0%) who interest-
ingly exhibited no prostatic involvement.
In recent years, surgeons have begun to report case 
series of minimally invasive radical cystectomy for the 
treatment of bladder cancer, including laparoscopic radi-
cal cystectomy (LRC) and robot-assisted radical cystec-
tomy (RARC), demonstrating the surgical feasibility of 
these procedure with the potential of reduced blood 
loss and more rapid return of bowel function and hospi-
tal discharge (Nix et  al. 2010; Challacombe et  al. 2011). 
LRC and RARC are increasingly performed; although 
open radical cystectomy (ORC) remains the standard 
approach for bladder cancer (Yuh et al. 2015; Stenzl et al. 
2011; Snow-Lisy et al. 2014; Bochner et al. 2014; Linder 
et al. 2014). Furthermore, Tyritzis et al. (2013) reported 
that outcomes after RARC with totally intracorporeal 
neobladder diversion appeared satisfactory and con-
sistent with a contemporary open series. Despite these 
excellent experiences and observations, high levels of 
clinical evidence with respect to the significance of ure-
thral management, such as LRC or RARC with simulta-
neous prophylactic urethrectomy, are lacking. Perineal 
urethrectomy has been reported to be a complicating 
procedure as a consequence of the extra perineal wound, 
longer operation duration and delayed ambulation, 
although radical cysto-urethrectomy is recommended 
for every patient with bladder cancer who has a urethral 
tumor or a risk of urethral reinvolvement (Elshal et  al. 
2011). Under this recent trend, minimally invasive surgi-
cal techniques have achieved increasing support and the 
decision making process regarding the urethra before 
and after cystectomy due to bladder cancer has become 
an even more difficult problem.
In our study, patients with lymph node-positive dis-
ease or those who were over 60 years old demonstrated 
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significantly worse survival and higher recurrence rates 
than those with no lymph node involvement or those 
who were younger than 60  years. However, there were 
no statistically significant differences in perioperative 
outcomes, except for the median operation time, onco-
logic outcomes and recurrence rates based upon the uri-
nary diversion approach. Remnant urethral recurrence 
was identified in only one patient (2.0%). These results 
are similar to the previous reports (Taylor et  al. 2010; 
Hautmann et  al. 2006). Our data indicate that anterior 
urethra sparing cystoprostatectomy for bladder can-
cer did not influence the incidence of remnant urethral 
recurrence and oncologic clinical outcome based upon 
different approaches to simultaneous urinary diversion. 
We believe that our study could be very useful in consid-
eration of the significance of simultaneous prophylactic 
urethrectomy with radical cystectomy, regardless of LRC, 
RARC, or ORC.
Our study is limited by the retrospective, non-rand-
omized design and by the small number of patients. A 
randomized clinical trial focused on the definitive ure-
thral management before and after minimally invasive 
radical cystectomy will be necessary in the future.
Conclusions
Our long-term data indicate that anterior urethra sparing 
cystoprostatectomy is an oncologically-safe procedure, 
regardless of the type of urinary diversion, in a subset of 
carefully selected patients with bladder cancer without 
evidence of urothelial carcinoma in the urethra/bladder 
neck or the urethral surgical margin.
Methods
Study population
We retrospectively reviewed the medical records of 56 
consecutive male patients who underwent an anterior 
urethra sparing cystoprostatectomy for primary bladder 
cancer at our institute between December 2000 and Sep-
tember 2013, who were included in a computerized data-
base containing comprehensive clinical and pathological 
data. All female patients were excluded. Patients were 
excluded from analysis when they did not have pathologi-
cal evidence of urothelial carcinoma or did not undergo 
IC or NB. The final pathological analysis was performed 
using routine step sectioning, which was the protocol 
during this period. The primary bladder lesion was classi-
fied using the TNM classification (Edge et al. 2010).
Treatment and follow‑up
Indication for radical cystectomy were muscle invasive 
bladder cancer (MIBC) or high-risk non MIBC (NMIBC) 
including multifocal T1 tumors, T1 tumors located in 
some difficult sites for complete resection, residual T1 
after re-resection, T1 with concomitant CIS, and BCG-
refractory tumors. This study cohort had undergone 
anterior urethra sparing cystoprostatectomy and uri-
nary diversion. Several forms of urinary diversion were 
selected, as follows: IC, NB and ureterocutaneostomy. 
Patient follow-up was relatively uniform and included 
urinary cytology, abdomen-pelvis computed tomography, 
whole-body bone scan, and chest X-ray. These tests were 
performed at 3-month intervals for the initial 2 years, at 
6-month intervals for the subsequent 3 years, and annu-
ally thereafter. Recurrence was confirmed by pathology 
findings and/or based on imaging findings in all patients 
classified as exhibiting tumor recurrence. The diagnosis 
of urethral recurrence was confirmed pathologically in 
the resected transurethral tissue samples.
Study methods
Clinical information was obtained by a retrospective 
review of all patient medical records. Preoperative tumor 
stage was determined according to the UICC. We inves-
tigated T stage, N stage, M stage, tumor grade, concomi-
tant CIS, and urethral surgical margin status. To rule 
out macroscopic tumor formation in the bladder neck, 
posterior or anterior urethra, all patients underwent pre-
operative urethrocystoscopy. Negative urethral surgical 
margins were confirmed by pathological diagnosis during 
surgery. The clinical and pathological characteristics of 
these patients are described in Additional file 1: Table S1.
Outcomes
We assessed the perioperative outcomes (operation time, 
blood loss, the number of hospitalization days, perioper-
ative complications), oncologic outcomes, including RFS 
and DSS, and recurrence rates according to the different 
approaches to simultaneous urinary diversion. RFS and 
DSS were defined as the time from anterior urethra spar-
ing cystoprostatectomy with simultaneous urinary diver-
sion until recurrence and the date of death from bladder 
cancer or last follow up, respectively. Patients were moni-
tored until death or loss to follow-up; the median val-
ues are reported for age at the time of operation and the 
duration of follow-up.
Statistical analysis
Results were analyzed using descriptive statistical analy-
sis. Survival data were analyzed using Kaplan–Meier 
survival estimates. The log-rank test was used to com-
pare RFS and DSS in the patient subgroups. Cox propor-
tional hazard regression models were used to evaluate 
independent prognostic factors associated with RFS and 
DSS in this patient cohort. Stat mate III for Windows was 
used for the statistical analyses and two-sided p-values 
<0.05 were considered significant.
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